515 related articles for article (PubMed ID: 9862685)
1. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
Kumar V; Sercarz E
J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
[TBL] [Abstract][Full Text] [Related]
2. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.
Kumar V; Tabibiazar R; Geysen HM; Sercarz E
J Immunol; 1995 Feb; 154(4):1941-50. PubMed ID: 7530748
[TBL] [Abstract][Full Text] [Related]
3. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
Cua DJ; Hinton DR; Stohlman SA
J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
[TBL] [Abstract][Full Text] [Related]
4. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
Javed NH; Gienapp IE; Cox KL; Whitacre CC
J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
[TBL] [Abstract][Full Text] [Related]
5. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
6. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice.
Offner H; Adlard K; Bebo BF; Schuster J; Burrows GG; Buenafe AC; Vandenbark AA
J Immunol; 1998 Sep; 161(5):2178-86. PubMed ID: 9725209
[TBL] [Abstract][Full Text] [Related]
8. Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells.
Kumar V; Coulsell E; Ober B; Hubbard G; Sercarz E; Ward ES
J Immunol; 1997 Nov; 159(10):5150-6. PubMed ID: 9366445
[TBL] [Abstract][Full Text] [Related]
9. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2.
Zhou SR; Whitaker JN; Han Q; Maier C; Blalock JE
J Immunol; 1994 Sep; 153(5):2340-51. PubMed ID: 7519648
[TBL] [Abstract][Full Text] [Related]
10. Differences between two strains of myelin basic protein (MBP) TCR transgenic mice: implications for tolerance induction.
Song F; Wardrop RM; Gienapp IE; Stuckman SS; Goverman J; Whitacre CC
J Autoimmun; 2002 Feb; 18(1):27-37. PubMed ID: 11869044
[TBL] [Abstract][Full Text] [Related]
11. T-T cellular interaction between CD4-CD8- regulatory T cells and T cell clones presenting TCR peptide. Its implication for TCR vaccination against experimental autoimmune encephalomyelitis.
Kozovska MF; Yamamura T; Tabira T
J Immunol; 1996 Aug; 157(4):1781-90. PubMed ID: 8759768
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain.
Hashim GA; Offner H; Wang RY; Shukla K; Carvalho E; Morrison WJ; Vandenbark AA
J Immunol; 1992 Oct; 149(8):2803-9. PubMed ID: 1401912
[TBL] [Abstract][Full Text] [Related]
13. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
[TBL] [Abstract][Full Text] [Related]
14. CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion.
Karpus WJ; Gould KE; Swanborg RH
Eur J Immunol; 1992 Jul; 22(7):1757-63. PubMed ID: 1378016
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice.
Grogan JL; Kramer A; Nogai A; Dong L; Ohde M; Schneider-Mergener J; Kamradt T
J Immunol; 1999 Oct; 163(7):3764-70. PubMed ID: 10490973
[TBL] [Abstract][Full Text] [Related]
16. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
[TBL] [Abstract][Full Text] [Related]
17. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Chen Y; Inobe J; Weiner HL
J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
[TBL] [Abstract][Full Text] [Related]
18. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
[TBL] [Abstract][Full Text] [Related]
19. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire.
McCue D; Ryan KR; Wraith DC; Anderton SM
J Neuroimmunol; 2004 Nov; 156(1-2):96-106. PubMed ID: 15465600
[TBL] [Abstract][Full Text] [Related]
20. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
